Four details:
1. Teladoc and Livongo closed the $18.5 billion deal in just under three months; the telehealth company announced the transaction Aug. 5.
2. Under the merger, Livongo shares will be exchanged for 0.5920 shares of Teladoc plus cash of $11.33 each consideration per share.
3. The transaction is valued at $18.5 billion based on Teladoc’s closing price Aug. 4.
4. On Oct. 15, Teladoc CEO Jason Gorevic filed a letter with the Securities and Exchange Commission stating that four of Livongo’s C-suite executives will leave after the merger is finalized. Those executives are: Livongo CEO Zane Burke, President Jennifer Schneider, MD, CFO Lee Shapiro, and Senior Vice President of Business Development Steve Schwartz.
More articles on telehealth:
Telehealth one year from today: 4 CIO predictions
MedStar Health reduces certain ED visit lengths by nearly 63% via telehealth
Fitbit CEO hints at company’s telemedicine plans
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
